Dendritic cell-based active specific immunotherapy for malignant glioma

Author： Parajuli Prahlad   Mathupala Saroj   Mittal Sandeep   Sloan Andrew E  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.7, Iss.4, 2007-04, pp. : 439-448

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RNA transfer and its use in dendritic cell-based immunotherapy

By Gust Tatjana C   Zenke Martin  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 2, 2005-02 ,pp. : 173-181

Informa Healthcare

Access to resources Recommend Favorite

Recent clinical development of dendritic cell-based immunotherapy for prostate cancer

By Rini Brian  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1729-1734

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell maturation in active immunotherapy strategies

By Morse Michael A   Mosca Paul J   Clay Timothy M   Lyerly H Kim  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 1, 2002-01 ,pp. : 35-43

Informa Healthcare

Access to resources Recommend Favorite

Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?

By Dillman Robert O   Cornforth Andrew N   Nistor Gabriel  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 643-656

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cell-based vaccines and therapies for cancer

By Tatsumi Tomohide   Storkus Walter J  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 919-928

Informa Healthcare

Access to resources Recommend Favorite